2024 Rome, Italy

I-28 Siak-Leng CHOI
Applying a quantitative system pharmacology (QSP) model to inform KRASG12C covalent inhibitorsí PK driver level needed for efficacy in patients with non-small cell lung cancer (NSCLC)
Wednesday 10:00-11:30